US Bancorp’s BioAmber Inc. BIOA Stock Holding History

US Bancorp’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-125	Closed	-$1K	–	3716
2016 Q3	$1K	Buy	+125	New	+$462	﹤0.01%	3498

Other funds holding BIOA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $4.73B AUM 58.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

US Bancorp's BIOA Position: Q4 2016 in Review

US Bancorp sold out of BioAmber Inc. (BIOA) in Q4 2016, closing a stake of 125 shares — an estimated $1K sold.

US Bancorp first reported a position in BIOA in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 32 funds tracked by Wall St. Rank hold BIOA as of Q4 2016.

US Bancorp reported no remaining BioAmber Inc. position as of Q4 2016 after selling out during the quarter.
US Bancorp sold 125 BioAmber Inc. shares in Q4 2016, an estimated $1K.
US Bancorp first reported a position in BioAmber Inc. in Q3 2016 and held it in 1 quarter.
US Bancorp's BioAmber Inc. position peaked at $1K in Q3 2016.
32 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2016.

Based on US Bancorp's 13F filing for Q4 2016, filed 8 Feb 2017.